Wednesday, April 7, 2010

Global market for genetic disorder products to reach $17.3 billion by 2014

Biotechnology Market Data Just Published by BCC Research

The global market for genetic disorder products was valued at $12.2 billion in 2008, which increased to $12.8 billion in 2009. Growing at a compound annual growth rate (CAGR) of 6.2%, this market is expected to be valued at nearly $17.3 billion by 2014.

Examine the market in chromosomal disorders, such as Down, Klinefelter’s, Prader-Willi, and Turner’s syndromes through 2014...

Use this report to:
  • Receive an overview of a range of genetic disorders, both mutation and chromosomal in nature, and provide global market summaries and new research and developments for treating genetic disorders
  • Understand the new developments in treating genetic disorders with product descriptions, discussions of new research, and company profiles from 2009 through 2014; as well as issues affecting the current and forecasted market, patent information and a list of key organizations covering genetic disorders.
  • See current product availability, uses of products, forecasts, and competitive analyses for a specific range of genetic disorders: Cystic Fibrosis, Fabry disease, Gaucher’s disease, Hemophilia, Huntington’s disease, Hunter syndrome, Hurler syndrome, Klinefelter syndrome, Maroteaux-Lamy syndrome, Phenylketonuria (PKU), Prader-Willi syndrome, Pompe disease, Turner’s syndrome.
  • Determine the areas of genetic disorders and the demand for new development that have emerged from biopharmaceutical companies, governments, private organizations, and universities with the current and potential market growth through 2014.
To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

No comments:

Post a Comment

Bookmark and Share